| 0.2 |
0.6 |
GO:0060166 |
olfactory pit development(GO:0060166) |
| 0.2 |
0.5 |
GO:0008228 |
opsonization(GO:0008228) modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
| 0.2 |
1.4 |
GO:0036371 |
protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) |
| 0.1 |
0.4 |
GO:0001803 |
antibody-dependent cellular cytotoxicity(GO:0001788) type III hypersensitivity(GO:0001802) regulation of type III hypersensitivity(GO:0001803) positive regulation of type III hypersensitivity(GO:0001805) |
| 0.1 |
0.4 |
GO:0035622 |
intrahepatic bile duct development(GO:0035622) cholangiocyte proliferation(GO:1990705) |
| 0.1 |
0.3 |
GO:0042822 |
vitamin B6 metabolic process(GO:0042816) pyridoxal phosphate metabolic process(GO:0042822) pyridoxal phosphate biosynthetic process(GO:0042823) |
| 0.1 |
1.1 |
GO:0042118 |
endothelial cell activation(GO:0042118) |
| 0.1 |
0.6 |
GO:0021856 |
cerebral cortex tangential migration using cell-axon interactions(GO:0021824) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) facioacoustic ganglion development(GO:1903375) |
| 0.1 |
0.3 |
GO:0021893 |
cerebral cortex GABAergic interneuron fate commitment(GO:0021893) |
| 0.1 |
0.5 |
GO:0097116 |
gephyrin clustering involved in postsynaptic density assembly(GO:0097116) |
| 0.1 |
0.3 |
GO:1904457 |
positive regulation of neuronal action potential(GO:1904457) |
| 0.1 |
0.4 |
GO:0060447 |
bud outgrowth involved in lung branching(GO:0060447) |
| 0.1 |
0.6 |
GO:2001023 |
regulation of response to drug(GO:2001023) |
| 0.1 |
0.2 |
GO:0042196 |
dichloromethane metabolic process(GO:0018900) chlorinated hydrocarbon metabolic process(GO:0042196) halogenated hydrocarbon metabolic process(GO:0042197) |
| 0.1 |
0.4 |
GO:0010991 |
negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.1 |
0.3 |
GO:0033600 |
negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
| 0.1 |
0.2 |
GO:0032430 |
positive regulation of phospholipase A2 activity(GO:0032430) activation of meiosis involved in egg activation(GO:0060466) |
| 0.1 |
0.2 |
GO:2000686 |
regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
| 0.1 |
0.3 |
GO:0032423 |
regulation of mismatch repair(GO:0032423) |
| 0.1 |
0.5 |
GO:0045650 |
negative regulation of macrophage differentiation(GO:0045650) |
| 0.1 |
0.3 |
GO:0010808 |
positive regulation of synaptic vesicle priming(GO:0010808) |
| 0.1 |
0.3 |
GO:2000987 |
positive regulation of fear response(GO:1903367) positive regulation of behavioral fear response(GO:2000987) |
| 0.1 |
0.2 |
GO:0045041 |
protein import into mitochondrial intermembrane space(GO:0045041) |
| 0.1 |
0.2 |
GO:1900157 |
regulation of bone mineralization involved in bone maturation(GO:1900157) |
| 0.1 |
0.2 |
GO:0002184 |
cytoplasmic translational termination(GO:0002184) |
| 0.1 |
0.2 |
GO:0070601 |
centromeric sister chromatid cohesion(GO:0070601) |
| 0.1 |
0.3 |
GO:0003211 |
cardiac ventricle formation(GO:0003211) |
| 0.1 |
0.5 |
GO:0061368 |
behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
| 0.1 |
0.6 |
GO:0014883 |
transition between fast and slow fiber(GO:0014883) positive regulation of stem cell population maintenance(GO:1902459) |
| 0.1 |
0.2 |
GO:0021577 |
hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) |
| 0.1 |
0.3 |
GO:0070305 |
response to cGMP(GO:0070305) cellular response to cGMP(GO:0071321) |
| 0.1 |
0.6 |
GO:0032096 |
negative regulation of response to food(GO:0032096) negative regulation of appetite(GO:0032099) |
| 0.1 |
0.2 |
GO:2001013 |
cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
| 0.1 |
0.3 |
GO:0006957 |
complement activation, alternative pathway(GO:0006957) |
| 0.1 |
0.2 |
GO:0060032 |
notochord regression(GO:0060032) |
| 0.1 |
0.1 |
GO:1901509 |
regulation of endothelial tube morphogenesis(GO:1901509) |
| 0.1 |
0.5 |
GO:0071420 |
cellular response to histamine(GO:0071420) |
| 0.0 |
0.1 |
GO:0051695 |
actin filament uncapping(GO:0051695) |
| 0.0 |
0.3 |
GO:1901524 |
regulation of autophagosome maturation(GO:1901096) regulation of macromitophagy(GO:1901524) negative regulation of macromitophagy(GO:1901525) |
| 0.0 |
0.5 |
GO:0007214 |
gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.0 |
0.4 |
GO:0061002 |
negative regulation of dendritic spine morphogenesis(GO:0061002) |
| 0.0 |
0.2 |
GO:0035609 |
C-terminal protein deglutamylation(GO:0035609) |
| 0.0 |
0.1 |
GO:0034729 |
histone H3-K79 methylation(GO:0034729) |
| 0.0 |
0.2 |
GO:1902268 |
negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.0 |
0.4 |
GO:0007379 |
segment specification(GO:0007379) |
| 0.0 |
0.1 |
GO:1902396 |
protein localization to bicellular tight junction(GO:1902396) |
| 0.0 |
0.2 |
GO:0006543 |
glutamine catabolic process(GO:0006543) |
| 0.0 |
0.8 |
GO:0010614 |
negative regulation of cardiac muscle hypertrophy(GO:0010614) |
| 0.0 |
0.2 |
GO:0001980 |
regulation of systemic arterial blood pressure by ischemic conditions(GO:0001980) |
| 0.0 |
0.2 |
GO:0033326 |
cerebrospinal fluid secretion(GO:0033326) |
| 0.0 |
0.2 |
GO:0060018 |
astrocyte fate commitment(GO:0060018) |
| 0.0 |
0.7 |
GO:0031987 |
locomotion involved in locomotory behavior(GO:0031987) |
| 0.0 |
0.2 |
GO:0019236 |
response to pheromone(GO:0019236) |
| 0.0 |
0.5 |
GO:0015732 |
prostaglandin transport(GO:0015732) |
| 0.0 |
0.4 |
GO:0019368 |
fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.0 |
0.6 |
GO:0016339 |
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.0 |
0.2 |
GO:0051790 |
short-chain fatty acid biosynthetic process(GO:0051790) |
| 0.0 |
0.9 |
GO:0007638 |
mechanosensory behavior(GO:0007638) |
| 0.0 |
0.1 |
GO:0071929 |
alpha-tubulin acetylation(GO:0071929) |
| 0.0 |
0.7 |
GO:0015812 |
gamma-aminobutyric acid transport(GO:0015812) |
| 0.0 |
0.1 |
GO:0038165 |
oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.0 |
0.4 |
GO:0033623 |
regulation of integrin activation(GO:0033623) |
| 0.0 |
0.6 |
GO:0006883 |
cellular sodium ion homeostasis(GO:0006883) |
| 0.0 |
0.2 |
GO:0032929 |
negative regulation of superoxide anion generation(GO:0032929) |
| 0.0 |
1.5 |
GO:0008542 |
visual learning(GO:0008542) |
| 0.0 |
1.0 |
GO:0032728 |
positive regulation of interferon-beta production(GO:0032728) |
| 0.0 |
0.2 |
GO:0014807 |
regulation of somitogenesis(GO:0014807) |
| 0.0 |
0.1 |
GO:0030644 |
cellular chloride ion homeostasis(GO:0030644) |
| 0.0 |
0.2 |
GO:0051036 |
regulation of endosome size(GO:0051036) |
| 0.0 |
0.1 |
GO:0010510 |
regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
| 0.0 |
0.1 |
GO:0014873 |
response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
| 0.0 |
0.3 |
GO:0045741 |
positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
| 0.0 |
0.1 |
GO:0045925 |
positive regulation of female receptivity(GO:0045925) |
| 0.0 |
0.1 |
GO:0090611 |
ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) positive regulation of extracellular exosome assembly(GO:1903553) |
| 0.0 |
0.5 |
GO:0045653 |
negative regulation of megakaryocyte differentiation(GO:0045653) |
| 0.0 |
0.1 |
GO:0070166 |
enamel mineralization(GO:0070166) |
| 0.0 |
0.1 |
GO:0071476 |
cellular hypotonic response(GO:0071476) |
| 0.0 |
0.1 |
GO:2000348 |
regulation of CD40 signaling pathway(GO:2000348) |
| 0.0 |
0.3 |
GO:0051764 |
actin crosslink formation(GO:0051764) |
| 0.0 |
0.0 |
GO:0021966 |
corticospinal neuron axon guidance(GO:0021966) |
| 0.0 |
0.2 |
GO:0048096 |
chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.0 |
0.4 |
GO:0060979 |
vasculogenesis involved in coronary vascular morphogenesis(GO:0060979) |
| 0.0 |
0.5 |
GO:0006054 |
N-acetylneuraminate metabolic process(GO:0006054) |
| 0.0 |
0.5 |
GO:0014047 |
glutamate secretion(GO:0014047) |
| 0.0 |
0.1 |
GO:2001271 |
negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.0 |
0.4 |
GO:0002495 |
antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) |
| 0.0 |
1.0 |
GO:0006891 |
intra-Golgi vesicle-mediated transport(GO:0006891) |
| 0.0 |
0.2 |
GO:1900383 |
regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.0 |
0.2 |
GO:0045899 |
positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
| 0.0 |
0.1 |
GO:0098915 |
membrane repolarization during ventricular cardiac muscle cell action potential(GO:0098915) |
| 0.0 |
0.1 |
GO:0097212 |
lysosomal membrane organization(GO:0097212) positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
| 0.0 |
0.1 |
GO:0090298 |
negative regulation of mitochondrial DNA replication(GO:0090298) |
| 0.0 |
0.2 |
GO:0071044 |
histone mRNA catabolic process(GO:0071044) |
| 0.0 |
0.2 |
GO:0000083 |
regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 0.0 |
0.1 |
GO:0030300 |
regulation of intestinal cholesterol absorption(GO:0030300) |
| 0.0 |
0.3 |
GO:0035641 |
locomotory exploration behavior(GO:0035641) |
| 0.0 |
0.2 |
GO:0060736 |
prostate gland growth(GO:0060736) |
| 0.0 |
0.1 |
GO:0090168 |
Golgi reassembly(GO:0090168) |
| 0.0 |
0.1 |
GO:0033314 |
mitotic DNA replication checkpoint(GO:0033314) |
| 0.0 |
0.2 |
GO:0046599 |
regulation of centriole replication(GO:0046599) |
| 0.0 |
0.2 |
GO:0008209 |
androgen metabolic process(GO:0008209) |
| 0.0 |
0.1 |
GO:2000483 |
detection of molecule of bacterial origin(GO:0032490) negative regulation of interleukin-8 secretion(GO:2000483) |
| 0.0 |
0.0 |
GO:0006597 |
spermine biosynthetic process(GO:0006597) |
| 0.0 |
0.3 |
GO:0032011 |
ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
| 0.0 |
0.2 |
GO:0043374 |
CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
| 0.0 |
0.2 |
GO:0071549 |
cellular response to dexamethasone stimulus(GO:0071549) |
| 0.0 |
0.1 |
GO:0030010 |
establishment of cell polarity(GO:0030010) |
| 0.0 |
0.3 |
GO:0009409 |
response to cold(GO:0009409) |
| 0.0 |
0.0 |
GO:0071677 |
positive regulation of mononuclear cell migration(GO:0071677) |
| 0.0 |
0.1 |
GO:0070842 |
aggresome assembly(GO:0070842) |
| 0.0 |
0.2 |
GO:0044381 |
glucose import in response to insulin stimulus(GO:0044381) regulation of glucose import in response to insulin stimulus(GO:2001273) |
| 0.0 |
0.0 |
GO:0007113 |
endomitotic cell cycle(GO:0007113) |
| 0.0 |
0.1 |
GO:0033601 |
positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
| 0.0 |
0.1 |
GO:0043116 |
negative regulation of vascular permeability(GO:0043116) |
| 0.0 |
0.1 |
GO:2001256 |
regulation of store-operated calcium entry(GO:2001256) |
| 0.0 |
0.0 |
GO:0051823 |
regulation of synapse structural plasticity(GO:0051823) |
| 0.0 |
0.2 |
GO:0006744 |
ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) |
| 0.0 |
0.8 |
GO:0030032 |
lamellipodium assembly(GO:0030032) |
